| CONTACTS: |
César García, Chairman and Chief Executive Officer |
|
818-709-1244
|
|
-or-
|
|
Ron Stabiner, The Wall Street Group, Inc. |
|
212-888-4848 |
CHATSWORTH, CA, May 22, 2008 - IRIS International, Inc. (NASDAQ: IRIS),
a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that its Annual Shareholder
Meeting will be held on Friday, June 13, 2008 at 10:00 a.m. Pacific time, at the Company's headquarters, 9172 Eton Avenue, Chatsworth, Calif. Shareholders and members of the
investment community are welcome to attend.
Following the formalities of the meeting, IRIS Chairman, President and Chief Executive Officer César García will give a business presentation,
followed by a tour of the Company's facilities and a demonstration of its new product offerings.
About IRIS International
IRIS International a leading global in vitro diagnostics company focused on products that analyze particles and living cell forms and structures, or morphology of
a variety of body fluids. Our products leverage our strengths in flow imaging technology, particle recognition and automation to bring efficiency to hospital and commercial laboratories.
The initial applications for our technology have been in the urinalysis market and we are the leading worldwide provider of urine microscopy systems, with an installed based of over
1,800 systems in over 50 countries.